? Centralized drug procurement organized by the state will bring great changes to people's drug
? Centralized drug procurement organized by the state will bring great changes to people's drug use. For example, centralized drug purchase organized by the state can effectively reduce the pressure on patients' drug purchase expenditure, so that some patients with rare diseases can afford life-saving drugs, thus bringing them hope of life and allowing people to use better drugs at lower centralized drug purchase prices.
? According to media reports, under the organization and guidance of the National Medical Insurance Bureau and other relevant departments, all provinces in China formed a procurement alliance to carry out the seventh batch of centralized drug procurement organized by the state, which produced a quasi-winning bid in Nanjing, Jiangsu Province on July 12. 60 kinds of drugs were successfully purchased in this centralized drug procurement, and the average price of the selected drugs was reduced by 48%. According to the agreed purchase volume, it is estimated that the annual cost can be saved by 654.38+085 billion yuan. Pharmaceutical enterprises actively participated in this centralized procurement, 488 products from 295 enterprises participated in the bidding, and 327 products from 2 17 enterprises were eligible to be selected. This drug collection involves 3 1 treatment category, including drugs for common and chronic diseases such as hypertension, diabetes, anti-infection and digestive tract diseases, as well as drugs for major diseases such as lung cancer, liver cancer, kidney cancer and intestinal cancer. The people benefit from a wide range and have a strong sense of gain. Taking the first-line targeted drugs for liver cancer as an example, the average per capsule dropped from 18 yuan to 18 yuan. Sustained and controlled release dosage forms were first included in the field of blood pressure reduction. The price of nifedipine controlled-release tablets was reduced by 58%, and that of metoprolol sustained-release tablets was reduced by 53%.
After reading this report, my friends and I sincerely praised the centralized drug procurement organized by the relevant state departments. When I graduated from university in 20 17, after several rounds of competition, I was hired by an internationally renowned pharmaceutical company in China, and my position was sales of drugs and medical devices. After joining the company, I learned from the communication with the hospital pharmacy room and doctors that the price increase of drugs is really too high, and I also witnessed the scene that my classmate's father was unable to buy targeted drugs, generic drugs and other life-saving drugs urgently needed for his illness treatment. At that time, I felt that if the country could implement large-scale procurement, wring out the water of stakeholders of these drugs and medical devices and make them available and affordable to small partners, that would be the real return to the standard and the heart of benevolent people.
In fact, what my friends and I expected has been organized and implemented by the relevant state departments. Starting from 20 18, the state began to organize pilot procurement with quantity in 4 municipalities directly under the central government and 7 sub-provincial cities, referred to as "4+7", and this year is the seventh time to organize centralized procurement of drugs. After centralized drug procurement in these countries, drug coverage has been further expanded. From the category of drugs, the centralized drug procurement organized by the state basically covers the mainstream drugs of chronic diseases and common diseases such as hypertension, diabetes, hyperlipidemia and chronic hepatitis B, which reduces the drug cost of the people, relieves the pressure of patients' drug purchase costs, and even makes some patients with rare diseases afford life-saving drugs, which brings them hope. As an insider, I think that centralized drug procurement not only solves the problem of expensive drugs for patients, but also makes them affordable. Moreover, pharmaceutical companies have changed from investing a lot of manpower and material resources to running the hospital to running the market, grasping quality and competing with their peers.
?
In my opinion, the centralized procurement of drugs organized by the state is based on solving the problem of expensive drugs for ordinary people, so that ordinary people can use drugs with higher quality and relatively lower price. It is indeed a project that benefits the people in one fell swoop.